author_facet Malerba, M.
Ragnoli, B.
Corradi, M.
Malerba, M.
Ragnoli, B.
Corradi, M.
author Malerba, M.
Ragnoli, B.
Corradi, M.
spellingShingle Malerba, M.
Ragnoli, B.
Corradi, M.
Monaldi Archives for Chest Disease
Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
Cardiology and Cardiovascular Medicine
Pulmonary and Respiratory Medicine
author_sort malerba, m.
spelling Malerba, M. Ragnoli, B. Corradi, M. 2465-1028 1122-0643 PAGEPress Publications Cardiology and Cardiovascular Medicine Pulmonary and Respiratory Medicine http://dx.doi.org/10.4081/monaldi.2008.390 <jats:p>Cigarette smoking is the major factor implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD), despite the fact that only susceptible smoking subjects develop this respiratory disease. In the last few years non–invasive techniques such as induced sputum (IS), exhaled nitric oxide (eNO) measurement and exhaled breath condensate (EBC) collection have been successfully established revealing an inflammatory status and oxidative stress indicators in the airways involved in the pathogenesis of several pulmonary diseases. Using these new non-invasive experimental tools recently, several efforts have been made to find new biomarkers in order to assess and monitor early lung damage induced by smoking. Tobacco smoke can acutely reduce eNO levels in healthy smokers and non-smoker subjects so it can play a role in anti-smoking programmes; its increase can be a positive parameter for subjects who are going to stop cigarette smoking and at the same time be used as an anti-smoking indicator. It can be useful to investigate the mechanism of cigarette-induced lung damage in an experimental setting and may potentially be useful for assessing of Environmental Tobacco Smoke (ETS) effects. Markers of oxidative stress have been detected in induced sputum of COPD subjects even though only few studies investigated the use of induced sputum to study smoke effects on the lungs of healthy subjects. Exhaled breath condensate (EBC) obtained by cooling exhaled air under conditions of spontaneous breathing is a promising biological fluid that could provide a real-time assessment of pulmonary pathobiology. The analysis of induced sputum and of exhaled air is feasible and non-invasive, can be useful to identify new biomarkers of exposure or susceptibility in COPD patients to enhance the understanding of airways changes due to current smoking and may be useful to find new biomarkers in order to assess and monitor early lung damage induced by smoke in order to prevent the progression of obstructive disease.</jats:p> Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects Monaldi Archives for Chest Disease
doi_str_mv 10.4081/monaldi.2008.390
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNDA4MS9tb25hbGRpLjIwMDguMzkw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNDA4MS9tb25hbGRpLjIwMDguMzkw
institution DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
imprint PAGEPress Publications, 2016
imprint_str_mv PAGEPress Publications, 2016
issn 2465-1028
1122-0643
issn_str_mv 2465-1028
1122-0643
language Undetermined
mega_collection PAGEPress Publications (CrossRef)
match_str malerba2016noninvasivemethodstoassessbiomarkersofexposureandearlystageofpulmonarydiseaseinsmokingsubjects
publishDateSort 2016
publisher PAGEPress Publications
recordtype ai
record_format ai
series Monaldi Archives for Chest Disease
source_id 49
title Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_unstemmed Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_full Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_fullStr Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_full_unstemmed Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_short Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_sort non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
topic Cardiology and Cardiovascular Medicine
Pulmonary and Respiratory Medicine
url http://dx.doi.org/10.4081/monaldi.2008.390
publishDate 2016
physical
description <jats:p>Cigarette smoking is the major factor implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD), despite the fact that only susceptible smoking subjects develop this respiratory disease. In the last few years non–invasive techniques such as induced sputum (IS), exhaled nitric oxide (eNO) measurement and exhaled breath condensate (EBC) collection have been successfully established revealing an inflammatory status and oxidative stress indicators in the airways involved in the pathogenesis of several pulmonary diseases. Using these new non-invasive experimental tools recently, several efforts have been made to find new biomarkers in order to assess and monitor early lung damage induced by smoking. Tobacco smoke can acutely reduce eNO levels in healthy smokers and non-smoker subjects so it can play a role in anti-smoking programmes; its increase can be a positive parameter for subjects who are going to stop cigarette smoking and at the same time be used as an anti-smoking indicator. It can be useful to investigate the mechanism of cigarette-induced lung damage in an experimental setting and may potentially be useful for assessing of Environmental Tobacco Smoke (ETS) effects. Markers of oxidative stress have been detected in induced sputum of COPD subjects even though only few studies investigated the use of induced sputum to study smoke effects on the lungs of healthy subjects. Exhaled breath condensate (EBC) obtained by cooling exhaled air under conditions of spontaneous breathing is a promising biological fluid that could provide a real-time assessment of pulmonary pathobiology. The analysis of induced sputum and of exhaled air is feasible and non-invasive, can be useful to identify new biomarkers of exposure or susceptibility in COPD patients to enhance the understanding of airways changes due to current smoking and may be useful to find new biomarkers in order to assess and monitor early lung damage induced by smoke in order to prevent the progression of obstructive disease.</jats:p>
container_issue 3
container_start_page 0
container_title Monaldi Archives for Chest Disease
container_volume 70
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792327564074680334
geogr_code not assigned
last_indexed 2024-03-01T12:39:21.825Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Non-invasive+methods+to+assess+biomarkers+of+exposure+and+early+stage+of+pulmonary+disease+in+smoking+subjects&rft.date=2016-01-25&genre=article&issn=1122-0643&volume=70&issue=3&jtitle=Monaldi+Archives+for+Chest+Disease&atitle=Non-invasive+methods+to+assess+biomarkers+of+exposure+and+early+stage+of+pulmonary+disease+in+smoking+subjects&aulast=Corradi&aufirst=M.&rft_id=info%3Adoi%2F10.4081%2Fmonaldi.2008.390&rft.language%5B0%5D=und
SOLR
_version_ 1792327564074680334
author Malerba, M., Ragnoli, B., Corradi, M.
author_facet Malerba, M., Ragnoli, B., Corradi, M., Malerba, M., Ragnoli, B., Corradi, M.
author_sort malerba, m.
container_issue 3
container_start_page 0
container_title Monaldi Archives for Chest Disease
container_volume 70
description <jats:p>Cigarette smoking is the major factor implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD), despite the fact that only susceptible smoking subjects develop this respiratory disease. In the last few years non–invasive techniques such as induced sputum (IS), exhaled nitric oxide (eNO) measurement and exhaled breath condensate (EBC) collection have been successfully established revealing an inflammatory status and oxidative stress indicators in the airways involved in the pathogenesis of several pulmonary diseases. Using these new non-invasive experimental tools recently, several efforts have been made to find new biomarkers in order to assess and monitor early lung damage induced by smoking. Tobacco smoke can acutely reduce eNO levels in healthy smokers and non-smoker subjects so it can play a role in anti-smoking programmes; its increase can be a positive parameter for subjects who are going to stop cigarette smoking and at the same time be used as an anti-smoking indicator. It can be useful to investigate the mechanism of cigarette-induced lung damage in an experimental setting and may potentially be useful for assessing of Environmental Tobacco Smoke (ETS) effects. Markers of oxidative stress have been detected in induced sputum of COPD subjects even though only few studies investigated the use of induced sputum to study smoke effects on the lungs of healthy subjects. Exhaled breath condensate (EBC) obtained by cooling exhaled air under conditions of spontaneous breathing is a promising biological fluid that could provide a real-time assessment of pulmonary pathobiology. The analysis of induced sputum and of exhaled air is feasible and non-invasive, can be useful to identify new biomarkers of exposure or susceptibility in COPD patients to enhance the understanding of airways changes due to current smoking and may be useful to find new biomarkers in order to assess and monitor early lung damage induced by smoke in order to prevent the progression of obstructive disease.</jats:p>
doi_str_mv 10.4081/monaldi.2008.390
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNDA4MS9tb25hbGRpLjIwMDguMzkw
imprint PAGEPress Publications, 2016
imprint_str_mv PAGEPress Publications, 2016
institution DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1
issn 2465-1028, 1122-0643
issn_str_mv 2465-1028, 1122-0643
language Undetermined
last_indexed 2024-03-01T12:39:21.825Z
match_str malerba2016noninvasivemethodstoassessbiomarkersofexposureandearlystageofpulmonarydiseaseinsmokingsubjects
mega_collection PAGEPress Publications (CrossRef)
physical
publishDate 2016
publishDateSort 2016
publisher PAGEPress Publications
record_format ai
recordtype ai
series Monaldi Archives for Chest Disease
source_id 49
spelling Malerba, M. Ragnoli, B. Corradi, M. 2465-1028 1122-0643 PAGEPress Publications Cardiology and Cardiovascular Medicine Pulmonary and Respiratory Medicine http://dx.doi.org/10.4081/monaldi.2008.390 <jats:p>Cigarette smoking is the major factor implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD), despite the fact that only susceptible smoking subjects develop this respiratory disease. In the last few years non–invasive techniques such as induced sputum (IS), exhaled nitric oxide (eNO) measurement and exhaled breath condensate (EBC) collection have been successfully established revealing an inflammatory status and oxidative stress indicators in the airways involved in the pathogenesis of several pulmonary diseases. Using these new non-invasive experimental tools recently, several efforts have been made to find new biomarkers in order to assess and monitor early lung damage induced by smoking. Tobacco smoke can acutely reduce eNO levels in healthy smokers and non-smoker subjects so it can play a role in anti-smoking programmes; its increase can be a positive parameter for subjects who are going to stop cigarette smoking and at the same time be used as an anti-smoking indicator. It can be useful to investigate the mechanism of cigarette-induced lung damage in an experimental setting and may potentially be useful for assessing of Environmental Tobacco Smoke (ETS) effects. Markers of oxidative stress have been detected in induced sputum of COPD subjects even though only few studies investigated the use of induced sputum to study smoke effects on the lungs of healthy subjects. Exhaled breath condensate (EBC) obtained by cooling exhaled air under conditions of spontaneous breathing is a promising biological fluid that could provide a real-time assessment of pulmonary pathobiology. The analysis of induced sputum and of exhaled air is feasible and non-invasive, can be useful to identify new biomarkers of exposure or susceptibility in COPD patients to enhance the understanding of airways changes due to current smoking and may be useful to find new biomarkers in order to assess and monitor early lung damage induced by smoke in order to prevent the progression of obstructive disease.</jats:p> Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects Monaldi Archives for Chest Disease
spellingShingle Malerba, M., Ragnoli, B., Corradi, M., Monaldi Archives for Chest Disease, Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine
title Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_full Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_fullStr Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_full_unstemmed Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_short Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_sort non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
title_unstemmed Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects
topic Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine
url http://dx.doi.org/10.4081/monaldi.2008.390